Amneal Pharmaceuticals Receives FDA Approval for Tramadol/APAP Tablets
2/8/2010
More...
|
IntelGenx Corp. Receives FDA Complete Response Letter CPI-300
2/8/2010
More...
|
Repros Therapeutics Inc. (RPRX) Submits Response to FDA Regarding Androxal(R) Indication for Treatment of Hypogonadal Men Wishing to Preserve Fertility
2/8/2010
More...
|
Anthera Pharmaceuticals, Inc. Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study
2/8/2010
More...
|
Keryx Biopharmaceuticals (KERX) Responds to Erroneous Report About Planned Phase III Study for Patients With Colorectal Cancer
2/8/2010
More...
|
Cara Therapeutics, Inc. Reports Positive Phase II Data for Novel Peripheral Analgesic in Acute Post-Operative Pain
2/8/2010
More...
|
Resverlogix Corporation (RVX.TO) Completes Patient Recruitment for ASSERT Trial
2/8/2010
More...
|
Kamada Ltd. Announces Enrollment of First Patient in Its Pivotal Study for Inhaled AAT in Europe
2/8/2010
More...
|
RegeneRx Biopharmaceuticals, Inc. (RGRX) Release: Researchers Report Elevated Levels of Tß4 Levels Predict Patient Survival in Hepatitis B Virus-related Liver Failure
2/8/2010
More...
|
Genta Incorporated (GETA.OB) Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advanced Melanoma
2/8/2010
More...
|
Vitrolife: Patient Recruitment to the Clinical Study on STEEN Solution(TM) is Now Complete
2/8/2010
More...
|
Inovio Biomedical Corporation (INO) Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trial
2/8/2010
More...
|
GeoVax Labs Inc. (GOVX.OB) Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA
2/8/2010
More...
|
Hemispherx Biopharma (HEB) Release: New Animal Model for Evaluating Antiviral Agents Against the SARS Virus Indicates Potential Effect of Ampligen(R), an Experimental Therapeutic
2/8/2010
More...
|
Synta PharmaceuticalsAnnounces STA-9090 Results Demonstrating Potent In vitro and In vivo Activity in AML
2/8/2010
More...
|
Affimed Therapeutics AG Successfully Completes Preclinical Development of AFM 13
2/8/2010
More...
|
Addex Pharmaceuticals (ADXN.SW): ADX71943 Demonstrates Analgesic Effects in Pain Models
2/8/2010
More...
|
Prescription Solutions Release: New Study Finds Specialized Support Programs Can Increase Treatment Adherence and Persistence, Reduce Relapses for People with Multiple Sclerosis
2/8/2010
More...
|
ExThera Medical Release: Study at the Karolinska Institute Suggests Potential for Reducing the High Death Rate from Sepsis, one of the Top-10 Causes of Death in the U.S.
2/8/2010
More...
|
EvoraPlus(TM) Probiotic Oral Care Product by Oragenics, Inc. (ONI)Launches In Walgreens
2/8/2010
More...
|